Back
Invesco FTSE RAFI Global Sm-Md ETF CAD Vs. Agios Pharmaceuticals Industry Stock Comparison
Buy
56
PZW.TO
Invesco FTSE RAFI Global Sm-Md ETF CAD
Last Price:
37.15
Seasonality Move:
0.69%
Sell
1
AGIO
Agios Pharmaceuticals
Last Price:
38.17
Seasonality Move:
12.89%
Buy
56
Invesco FTSE RAFI Global Sm-Md ETF CAD (PZW.TO)
is a Buy
Is Invesco FTSE RAFI Global Sm-Md ETF CAD a Buy, Sell or Hold?
- The current Invesco FTSE RAFI Global Sm-Md ETF CAD [PZW.TO] share price is $37.15. The Score for PZW.TO is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- PZW.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
1
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $38.17. The Score for AGIO is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PZW.TO Stock Price Chart
What is Invesco FTSE RAFI Global Sm-Md ETF CAD's stock price today?
-
The Invesco FTSE RAFI Global Sm-Md ETF CAD share price today is $37.15
The current trend is moderately bullish and PZW.TO is experiencing slight buying pressure.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $38.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing selling pressure, which indicates risk of future bearish movement.
PZW.TO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.4 | Buy |
| Relative Strength Index (14 RSI): | 65.42 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.02 - 37.16) | Buy |
| Bollinger Bands (100): | (34.12 - 36.3) | Buy |
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.34 | Sell |
| Relative Strength Index (14 RSI): | 26.34 | Sell |
| Chaikin Money Flow: | -1550643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.73 - 60.93) | Sell |
| Bollinger Bands (100): | (42.01 - 53.19) | Sell |
PZW.TO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.17 | Sell |
| 20-day SMA: | 36.68 | Buy |
| 50-day SMA: | 35.94 | Buy |
| 200-day SMA: | 34.05 | Buy |
| 8-day EMA: | 37.12 | Buy |
| 20-day EMA: | 36.77 | Buy |
| 50-day EMA: | 36.09 | Buy |
| 200-day EMA: | 34.18 | Buy |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.89 | Sell |
| 20-day SMA: | 54.55 | Sell |
| 50-day SMA: | 49.66 | Sell |
| 200-day SMA: | 41.9 | Sell |
| 8-day EMA: | 48.9 | Sell |
| 20-day EMA: | 52.35 | Sell |
| 50-day EMA: | 50.92 | Sell |
| 200-day EMA: | 42.82 | Sell |
Invesco FTSE RAFI Global Sm-Md ETF CAD Earnings Growth & PZW.TO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
Invesco FTSE RAFI Global Sm-Md ETF CAD Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agios Pharmaceuticals Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||